During a cross-validation practice of urinary analysis of pyrethroid insecticide metabolite (3-phenoxybenzoic acid, 3-PBA) by two laboratories (Lab A and Lab B), difference in 3-PBA concentration was noticed. The analytical methods used in the exercise were enzymatic deconjugation (glucuronidase/sulfatase) followed by solid phase extraction and isotope dilution LC -MS-MS determination (Lab A) and acidic deconjugation followed by liquid -liquid extraction and gas chromatography -mass spectrometry determination (Lab B). A significant difference was found for one of the five samples: lower value was obtained in Lab A. Use of acidic deconjugation in Lab A resulted in comparable value with the analytical result for this sample originally obtained in Lab B. The comparison was extended to 42 urine samples taken from Japanese males in Lab A by using the two different deconjugation methods and LC-MS-MS determination. Significantly lower value was obtained for enzymatic deconjugation in some of the 42 urine samples. The results suggested the presence of other conjugated species of 3-PBA than glucuronide and sulfate in human urine. Although the overall agreement between the values obtained by the deconjugation methods was fair, it appears that urine samples should be pretreated by acidic deconjugation for the analysis in biological monitoring of pyrethroid exposure.
Introduction
Pyrethroid insecticides are extensively used for agricultural and household use in the world. Although its acute toxicity to mammals was known to be minimal, its potential endocrine effects have become a matter of public concern. Effects on reproductive and endocrine systems have been examined by in vivo experiments as well as by occupational and environmental epidemiology. In these epidemiologic studies, the biomarker approach has widely been employed for exposure assessment. Urinary levels of metabolites have been considered a reliable biomarker of exposure to pyrethroid insecticides. In some previous studies, association was found between urinary metabolite concentration and semen quality (1 -3) and hormone levels (4, 5) in occupational and environmental settings, but not in all (6, 7) . In addition, human urinary analysis has been extensively carried out for biological monitoring purpose (8 -14) .
There are two types of analytical methods for the analysis of urinary pyrethroid metabolites: one is gas chromatographymass spectrometry (GC -MS) preceded by derivatization (e.g., 15, 16 ) and the other is liquid chromatography -tandem mass spectrometry (LC -MS-MS) (17, 18) . These two methods are sensitive, selective and accurate, and they are widely used in many laboratories. The present authors also use these methods in routine analysis of 3-phenoxybenzoic acid (3-PBA), one of major common metabolites of a number of pyrethroid insecticides.
Because analytical quality assurance is requisite in any analytical laboratories, the authors intended to cross-validate the urinary 3-PBA determination using independent analytical methods (GC-MS and LC -MS-MS) and common urine samples for external quality assurance purpose. During the practice, we found a source of bias in the analytical results of 3-PBA concentration in urine, which is reported in this article.
Materials and methods
In this study, two different laboratories (Lab A and Lab B) were involved for cross-validation of urinary 3-PBA determination with different analytical methods being routinely used in each laboratory.
Urine samples for laboratory cross-validation were taken from five university students (two males and three females) without known pyrethroid exposure after obtaining informed consent. Single void of urine from each student was dispensed into several polypropylene tubes, which had been cleaned by rising with HPLC grade methanol before use, and frozen. The five urine samples were analyzed independently in Lab A and Lab B. Urine samples from 42 Japanese males, who were outpatients of a gynecology clinic in Tokyo for infertile consultation, were sampled during February to August, 2010 for a pilot survey on the association between pyrethroid exposure and semen quality in Lab A (19) . This set of samples was analyzed only in Lab A.
Urinary concentration of 3-PBA was determined in Lab A by the isotope dilution LC -MS-MS method that was based on Baker et al. (17) with a minor modification under gradient conditions for LC. The method involved addition of 13 C-3-PBA, enzymatic deconjugation [added 20 mL of Type H-2 glucuronidase (100,000 units/mL)/sulfatase (7,500 units/mL) (Sigma-Aldrich) to 2 mL of urine and incubated at 378C for 5 h], solid phase extraction (Oasis HLB, 150 mg/6 cc, Waters), elution with methanol, drying with N 2 , re-dissolving with water -acetonitrile (50:50) and determination by LC -MS-MS. Liquid chromatography was Agilent 1100 LC (Agilent Technologies Japan, Tokyo, Japan) and MS used was Quattro Ultima (Micromass, UK). The detection limit of 3-PBA in Lab A was 0.04 ng/mL, which was equal to the concentration corresponding to signal-to-noise ratio 3. Note that incubation time of enzymatic deconjugation was 17 h in the original procedure, however, our examination (2 -17 h) found constant 3-PBA concentration at .3 h incubation time.
In Lab B, urinary 3-PBA concentration was determined by the GC -MS method according to Leng and Gries (16) . It involved addition of internal standard (2-PBA), deconjugation with HCl (added 0.5 mL HCl to 2 mL urine and heated at 1008C for 2 h), extraction with tert-butyl-methyl ether, derivatization with 1,1,1,3,3,3-hexafluoroisopropanol and N,N-diisopropylcarbodiimide (SigmaAldrich) and determination by GC -MS (Agilent 5975 MDS; Agilent Technologies Japan). The detection limit of 3-PBA in Lab B was 0.02 ng/mL , which was obtained by the identical method to Lab A.
Extensive internal quality control practice for urinary 3-PBA analysis has been employed in both of the laboratories by employing blank measurements, recovery test, analysis of in-house control urine samples, etc. (10).
Results and discussion
The concentrations of 3-PBA in the five urine samples determined in Lab A and Lab B were compared in Table I . The agreement was satisfactory except for one sample (ID 3): 3-PBA in that sample was 1.11 ng/mL in Lab A and 2.26 ng/mL in Lab B. When analysis was repeated in Lab A with the same LC-MS-MS method but enzymatic deconjugation was replaced with acidic hydrolysis as employed in Lab B, a higher value (2.74 ng/mL) was obtained for ID 3 sample. No substantial difference was found for the rest of the samples between the 3-PBA values obtained by enzymatic and acidic deconjugation. Figure 1 shows the agreement of analytical values of urinary 3-PBA in Lab A and Lab B when the acidic deconjugation procedure was employed in both laboratories. The slope and R 2 of the fitted regression was 0.88 and 0.977, respectively. They were affected by the presence of small disagreement for ID3 (2.26 vs 2.74 ng/mL). However, it can be said that the agreement was satisfactory given that totally different analytical methods, i.e., extraction, chromatography and detection, had been used in the two laboratories. This result indicated the reliability of routine urinary 3-PBA determination in the two laboratories. Barr et al. (20) compared analytical results of urinary pyrethroid/pyrethrum metabolite determinations by GC -MS preceded either by solid phase extraction and liquid -liquid extraction and those by LC -MS-MS. They also found similar analytical characteristics for 3-PBA among the methods they tested.
The present result carries relevance because it indicated the presence of 3-PBA in human urine conjugated to unidentified ligand other than glucuronide and sulfate. Although animal studies showed that not only free and glucuronide conjugate but also glycine conjugate was detected as major excretion forms of 3-PBA after synthetic pyrethroid ( permethrin) dosing to rats (21) , some of the previous human urine biological monitoring studies used glucuronidase/sulfatase for deconjugation. We repeated urine sampling from ID 3 and analyzed by isotope dilution LC -MS-MS preceded by both of the deconjugation methods in Lab A to see if other conjugate(s) other than glucuronide and sulfate was always present in this particular subject. Further analyses of urine samples from this subject by the two deconjugation methods revealed no significant disagreement in the five additional urine samples collected on different days. It indicated that the presence of other conjugate(s) other than glucuronide and sulfate in urine of ID 3 subject could be variable probably due to physiological or other factors and was not persistent to particular subject (e.g., genetic).
We further analyzed 3-PBA concentrations in urine samples from 42 Japanese males (19) using both enzymatic and acidic deconjugation followed by isotope dilution LC -MS-MS in Lab A. The result is shown in Figure 2 . The agreement between the analytical values of 3-PBA by enzymatic and acidic deconjugation was excellent except for one sample showing the highest concentration as is apparent in this figure. The Bland -Altman plot for enzymatic and acid deconjugated urine samples was shown in Figure 3 . The 95% confidence interval of the difference (enzyme -acid) was 20.101 to 0.018 ng/mL. However, when the difference between log-transformed 3-PBA concentrations preceded by enzymatic and acidic deconjugation was compared by the paired t-test, it was significant (t ¼ 22.495, P ¼ 0.017). It was also significant when Wilcoxon's signed-rank test was applied to crude concentrations (P ¼ 0.007). Thus, it can be concluded that analysis of 3-PBA preceded by enzymatic deconjugation could likely to result in underestimation especially for some urine samples shown as outlier values in the Bland-Altman plot. This could be ascribed to the notion that some urine samples had other conjugates of 3-PBA than glucuronide and sulfate as discussed above. Analysis of conjugated forms of 3-PBA will clarify the proportion of glucuronide, sulfate, glycine or any other conjugates in human urine.
Conclusion
Comparison of analytical values of urinary 3-PBA, one of major metabolites of insecticide pyrethroid, with different routine analytical methods (LC -MS-MS and GC -MS) revealed generally good agreement between the methods but significant difference for some samples could take place: lower value was likely to be obtained in the analysis preceded by enzymatic deconjugation than that by acidic deconjugation. This was probably because there were other conjugate forms of 3-PBA other than glucuronide and sulfate. It is advisable to use acidic deconjugation for the biological monitoring of pyrethroid exposure by urine analysis.
